New Onset T1D Studies

Study Name	Principal Investigator
Long Term Investigative Follow-Up in TrialNet (LIFT) Study	Desmond Schatz, M.D.
Immune Function During Various Stages of Insulin Dependent Diabetes	Mark Atkinson, Ph.D.
Non-Invasive Assessment of Pancreatic Volume as a Tool to Augment Risk Stratification in Patients at Risk for Type 1 Diabetes	Michael Haller, M.D.
A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes (T1GER)
Lactobacillus Johnsonii Supplementation in Children and Adults With T1D	Michael Haller, M.D.
DiabeteS AUtoimmuNity WithdRawn In New OnSEt and In Established Patients (SUNRISE) A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety of TOL-3021 in Patients with New Onset or Established Type 1 Diabetes Mellitus	Laura Jacobsen, M.D.